Skip to main content
Signal8

Quantum Biopharma Ltd. (QNTM)

Quantum BioPharma Ltd., a biopharmaceutical firm headquartered in Toronto, Canada, is dedicated to the discovery and advancement of biotechnological solutions and drug candidates. The company focuses on addressing complex neurodegenerative, inflammatory, and metabolic conditions, alongside alcohol use disorder, with its pipeline featuring a range of drug candidates at varying stages of development. Its operations are divided into two main divisions: its core biopharmaceutical activities and strategic investment holdings. A flagship asset is Lucid-MS, a novel, proprietary chemical entity currently in Phase 2 clinical trials. Preclinical data indicates its potential to prevent and reverse the degradation of myelin, a key process underlying multiple sclerosis. Furthermore, Quantum BioPharma is developing a therapeutic solution for alcohol addiction, intended for application in hospital and clinical environments. The company's strategic investments portfolio includes various loans collateralized by residential real estate. Previously known as FSD Pharma Inc., the company adopted its current name, Quantum BioPharma Ltd., in August 2024.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Quantum BioPharma Ltd. logo

Quantum BioPharma Ltd.

NASDAQ:QNTMHealthcare
-2.46%$2.38
AH$2.38+0.00%vs close
Mkt Cap$19.25M
Float5.39M
O/S8.09M
Vol
$ Vol
RVOL
Inst Own5.1%
SI9.7%
Earnings
Dilution
Financials Summary
Revenue$0
Net Income-$26.18M
Total Assets$11.14M
Free Cash Flow-$8.38M
Debt & Equity
Debt 21%
Equity 79%
Total Debt$1.87M
Total Equity$6.91M
Shares Outstanding
Short Interest
Split History2 splits · 1 reverse
  1. 20:1Forward split
    Aug 15, 20241 share → 20
  2. 1:201Reverse split
    Oct 16, 2019201 shares → 1
Balance Sheet Details
Assets$11.14M
Liabilities$6.05M
Accounts Receivable$231K
Accounts Payable$0
Inventory$52K
PP&E (Net)$169K
Goodwill$0
Intangible Assets$4.5M
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
CurrencyUSDUSDUSDUSDUSDUSDCADCADCADCADCAD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-08-312015-08-31
Revenue$0$0$0$0$0$0$0$0$21K$0$0
YoY Growth-----------
Cost of Revenue$0$0$0$0$0$0$0$183K$0$0$0
Gross Profit$0$0$0$0$0$0-$2.65M-$183K$21K$0$0
Gross Margin--------100.0%--
Research and Development$2.76M$6.08M$3.86M$6.91M$6.33M$7.83M$0$0$0$0$0
Selling, General, and Administrative$12.01M$9.31M$13.2M$15.98M$23.37M$18.11M$20.49M$17.49M$2.82M$30K$33K
Other$531K$743K$6.73M$4.54M$4.05M$4.75M$9.46M$1.13M$0$148K$0
Total Operating Expenses$15.3M$16.14M$23.79M$27.43M$33.74M$30.69M$29.95M$18.62M$2.82M$178K$33K
Operating Income (EBIT)-$15.3M-$16.14M-$23.79M-$27.43M-$33.74M-$30.69M-$30.58M$0-$2.8M$0$0
Operating Margin---------13586.0%--
Interest Expense$619K$48K$299$49K$69K$236K$155K$0$0$0$0
Interest Income$236K$573K$786K$368K$1K$4K$0$0$0$0$0
Other Income (Expense)-$11.65M$1.22M$5.56M$726K-$194K$2.24M-$15.88M-$16.67M$0-$30K-$33K
Income Before Tax (EBT)-$26.96M-$14.92M-$18.23M-$26.7M-$33.94M-$28.45M-$46.45M-$16.67M-$2.8M-$30K-$33K
Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0
Net Income-$26.18M-$14.2M-$17.9M-$23.61M-$35.29M-$31.8M-$39.13M-$22.64M-$2.8M-$30K-$33K
Net Income Margin---------13586.0%--
Supplementary Data
EPS-8.11-12.49-29.39-39.62-65.63-171.62-360.45-183.54-27.75-0.29-0.32
Diluted EPS-8.11-12.49-29.39-39.62-65.63-171.62-360.45-183.54-27.75-0.29-0.32
Weighted Average OS3.29M1.14M609,056595,882537,618185,291108,55790,848101,000101,000101,000
EBITDA-$25.79M-$14.38M-$15.72M-$22.12M-$29.82M-$24.32M-$31.98M-$16.54M-$2.8M-$30K-$33K
EBITDA Margin---------13586.0%--
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
CurrencyUSDUSDUSDUSDUSDUSDCADCADCADCADCAD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-08-312015-08-31
Assets
Current Assets
Cash and Cash Equivalents$1.9M$6M$2.76M$16.98M$35.26M$17.52M$5.97M$15.52M$3.77M$7K$0
Short-Term Investments$4.27M$1.2M$756K$23K$158K$0$0$0$0$0$0
Cash and Short-Term Investments$6.17M$7.2M$3.51M$17M$35.42M$17.52M$5.97M$15.52M$3.77M$7K$0
Accounts Receivable$231K$3.81M$7.42M$374K$501K$161K$1.56M$980K$234K$0$2K
Inventory$52K$117K$0$0$0$0$709K$0$0$0$0
Other Current Assets$13K$861K$0$0$8.65M$8.61M$0-$252K$0$0$0
Total Current Assets$6.47M$12.05M$11.09M$17.85M$45.93M$26.87M$8.56M$16.57M$4.28M$7K$2K
Long-Term Assets
Property, Plant & Equipment Net$169K$130K$120K$261K$168K$0$8.98M$8.91M$6.59M$0$0
Goodwill$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$4.5M$4.93M$5.36M$12.04M$16.2M$13.42M$16.82M$0$0$0$0
Long-Term Investments$0$2K$6K$828K$660K$1.68M$8.86M$13.26M$0$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$0$0$907K$7.43M$0$0$0$0$0$0$0
Total Long-Term Assets$4.67M$5.07M$6.39M$20.56M$17.03M$15.1M$34.66M$22.18M$6.59M$0$0
Other Assets$0$0$0$0$0$0$0$0$0$0$0
Total Assets$11.14M$17.12M$17.47M$38.41M$62.96M$41.97M$43.22M$38.75M$10.88M$7K$2K
Liabilities
Current Liabilities
Accounts Payable$0$3.25M$3.24M$2.76M$3M$2.06M$3.36M$1.28M$1.01M$28K$37K
Short-Term Debt$1.87M$771K$301K$301K$301K$385K$1.44M$0$0$0$18K
Current Income Tax Payable$0$0$0$0$0$0$0$0$0$0$0
Current Unearned Revenue$0$1M$0$0$0$0$0$0$0$0$0
Other Current Liabilities$4.17M$492K$31K$244K$811K$1.61M$1.99M$0$0$0$0
Total Current Liabilities$6.05M$6.68M$4.57M$7.83M$8.7M$5.58M$6.83M$1.28M$1.01M$61K$61K
Long-Term Liabilities
Long-Term Debt$0$0$0$0$0$0$0$0$0$0$0
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$0$0$0$0$0$0$0$0$0$0$0
Total Long-Term Liabilities$0$0$0$38K$131K$79K$110K$0$0$0$0
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities$6.05M$6.68M$4.57M$7.87M$8.83M$5.66M$6.94M$1.28M$1.01M$61K$61K
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$0$0$0
Common Stock$169.39M$150.47M$137.78M$143.41M$152.32M$103.21M$73.74M$49.87M$10.34M$1.07M$1.06M
Retained Earnings-$197.93M-$172.11M-$157.91M-$144.16M-$126.15M-$90.87M-$59.07M-$19.46M-$3.35M-$1.3M-$1.26M
Comprehensive Income & Other$101K$51K$417K$653K$240K$208K-$85K$0$0$0$0
Other Stockholders' Equity$35.44M$33.12M$33.37M$31.3M$27.96M$23.97M$21.61M$7.05M$2.88M$178K$142K
Total Equity$6.91M$11.48M$13.24M$30.54M$54.13M$36.31M$36.28M$37.47M$9.87M-$54K-$58K
Minority Interest-$1.82M-$1.04M-$328K$0$0$0$0$0$0$0$0
Total Liabilities and Equity$12.96M$18.16M$17.8M$38.41M$62.96M$41.97M$43.22M$38.75M$10.88M$7K$2K
Supplementary Data
Total Debt$1.87M$825K$339K$516K$556K$511K$1.59M$0$0$0$18K
Net Debt-$29K-$5.17M-$2.42M-$16.46M-$34.7M-$17.01M-$4.38M-$15.52M-$3.77M-$7K$18K
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
CurrencyUSDUSDUSDUSDUSDUSDCADCADCADCADCAD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-08-312015-08-31
Operating Activities
Net Income-$26.18M-$14.92M-$18.23M-$26.7M-$33.94M-$28.45M-$34.08M-$16.67M-$2.81M-$30K-$33K
Depreciation & Amortization$546K$491K$2.51M$4.53M$4.05M$3.9M$1.94M$135K$0$0$0
Deferred Income Tax$0$0$0$0$0$0$0$0$0$0$0
Stock-Based Compensation$2.95M$152K$3.84M$1.53M$7.44M$8.05M$12.08M$4.73M$2.38M$0$0
Changes in Working Capital:
  Accounts Receivable$1.72M$4.52M-$729K-$7.22M-$107K$435K-$388K-$488K-$218K$2K$881
  Inventory$66K-$117K$0$0$0$0-$722K$0$0$0$0
  Accounts Payable$1.2M$0$0$0$0$0$825K$318K$791K-$9K$13K
  Other Working Capital-$963K$5.36M$2.37M$96K$3M$372K$1.39M-$73K-$268K$9K$19K
Total Working Capital Change$2.02M$9.76M$1.64M-$7.12M$2.89M$807K$1.1M-$242K$305K$2K$33K
Other Non-Cash Items$12.28M-$2.36M-$576K-$575K-$1.19M-$3.44M$5.24M-$1.52M$10K$0$0
Net Cash from Operating-$8.38M-$6.88M-$10.83M-$28.33M-$20.75M-$19.13M-$13.71M-$13.58M-$119K-$27K-$63
Investing Activities
Capital Expenditures$0$0$0-$114K-$500K$0-$409K-$2.96M-$6.09M$0$0
Acquisitions$0$0$32K$0$769K$0$2K$1.5M$0$0$0
Purchases of Investments-$6.2M-$7.69M-$745K-$402K$0$0$0-$5.87M$0$0$0
Sales of Investments$4.21M$6.19M$443K$12.89M$0$6.48M$462K$0$0$0$0
Other Investing Activities$0$0$0-$250K$0$37K-$286K$0$0$0$0
Net Cash from Investing-$1.99M-$1.5M-$270K$12.12M$269K$6.51M-$231K-$7.34M-$6.09M$0$0
Financing Activities
Debt Repaid$114K$64K$189K$143K$58K$40K$42K----
Common Stock Issuance$539K$10.67M$34$0$38.34M$25.1M$3.43M$33.03M$10.96M$66K$0
Common Stock Repurchases$0$0-$2.96M-$1.93M$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities$424K$0$20K$0$0$60K$623K-$82K-$1.01M-$32K$0
Net Cash from Financing$6.21M$11.62M-$3.13M-$2.07M$38.21M$24.17M$4.01M$32.95M$9.95M$34K$0
Forex Effect$72K$0$0$0$0$0$0$0$0$0$0
Net Change in Cash-$4.09M$3.24M-$14.22M-$18.28M$17.73M$11.56M-$9.93M$12.04M$3.75M$7K-$63
Supplementary Data
Operating Cash Flow-$8.38M-$6.88M-$10.83M-$28.33M-$20.75M-$19.13M-$13.71M-$13.58M-$119K-$27K-$63
Capital Expenditure$0$0$0-$364K-$500K$0-$293K-$2.96M-$6.09M$0$0
Free Cash Flow-$8.38M-$6.88M-$10.83M-$28.7M-$21.25M-$19.13M-$14.01M-$16.54M-$6.21M-$27K-$63
Cash at Beginning$5.99M$2.76M$16.98M$35.26M$17.52M$5.97M$15.9M$3.48M$24K$0$63
Cash at End$1.9M$6M$2.76M$16.98M$35.26M$17.52M$5.97M$15.52M$3.77M$7K$0